Is Eli Lilly Stock a Buy, Sell, or Fairly Valued After Its 2023 Rally?
With a 30% rally on optimism about two key drug lines, here’s what we think of Eli Lilly stock.
Source: morningstar.com
Page 44 - Value Estimate News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Value Estimate. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Value Estimate Today - Breaking & Trending Today
/cloudfront-us-east-1.images.arcpublishing.com/morningstar/7TFN7NDQ5ZHI3PCISRCSC75K5U.png)
Consumer Defensive Stock Outlook: Competitively Advantaged Firms Positioned to Withstand Promotional Resurge and Evolving Consumer Behavior
We see opportunities in consumer-packaged goods and the alcoholic beverages space.
Source: morningstar.com
Healthcare Stock Outlook: Innovative Products and Defensive Nature Should Support Solid Results in Uncertain Times
We see plenty of opportunities in healthcare, especially in biopharma, healthcare providers, healthcare plans, and diagnostics and research.
Source: morningstar.com
/cloudfront-us-east-1.images.arcpublishing.com/morningstar/GRX7CQPD3FDX7A6SEP7DEH43LU.png)
Industrials Stock Outlook: Fewer Stocks Are Undervalued, but Investment Opportunities Still Exist
Easing supply chains and a more constructive outlook on the global economy have benefited the industrial distribution and industrial products businesses.
Source: morningstar.com
/cloudfront-us-east-1.images.arcpublishing.com/morningstar/W72KQKIKI5ALNJPFHG7LM4CHQQ.png)
Utilities Stock Outlook: Still Running In Place
The sector has remained flat due in large part to a long-overdue valuation correction.
Source: morningstar.com